HealthQuill blood sugar levels
Eli Lilly and Company will acquire SiteOne Therapeutics, Inc. for $1 billion to get access to an inhibitor that may cure chronic pain without using opioids.
Drugs Health Pharma

Novo Nordisk, Septerna in $2.2b deal to develop oral molecules

HQ Team May 14, 2025: Novo Nordisk and Septerna, Inc., have inked a $2.2 billion global collaboration and licensing pact to develop oral.

Read More
Denmark's Novo Nordisk plans to effect a 75% cut in insulin prices in the U.S. market by January 1, 2024.
Drugs Health Medical

Oral insulin successfully tested on animals, human trials set for 2025

Bharti Jayshankar February 5, 2024: Scientists have developed a form of oral insulin, offering an alternative to traditional syringes or insulin pumps. The.

Read More